Related Experiment Video
Updated: May 13, 2026

Assays for the Identification of Novel Antivirals against Bluetongue Virus
Published on: October 12, 2013
Advanced antisense therapies for postexposure protection against lethal filovirus infections
Travis K Warren1, Kelly L Warfield, Jay Wells
1United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA.
Abstract:
Currently, no vaccines or therapeutics are licensed to counter Ebola or Marburg viruses, highly pathogenic filoviruses that are causative agents of viral hemorrhagic fever. Here we show that administration of positively charged phosphorodiamidate morpholino oligomers (PMOplus), delivered by various dosing strategies initiated 30-60 min after infection, protects>60% of rhesus monkeys against lethal Zaire Ebola virus (ZEBOV) and 100% of cynomolgus monkeys against Lake Victoria Marburg virus (MARV) infection. PMOplus may be useful for treating these and other highly pathogenic viruses in humans.

